Korro Bio, Inc. (KRRO): Total Assets
$113.51M
As of 2025-12-31
$163.45M
As of 2026-06-30
+15.5%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $113.51M | -49.8% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $226.24M | +2.1% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $221.66M | +200.6% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $73.74M | n/c | 2024-03-26, Balance as of period end |
| 2021-12-31 | $185.36M | -30.0% | 2023-03-10, Balance as of period end |
| 2020-12-31 | $264.72M | +18.6% | 2022-03-15, Balance as of period end |
| 2019-12-31 | $223.22M | +401.1% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $44.55M | n/a | 2020-03-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $113.51M | -49.8% |
| Immunome Inc. (IMNM) | 2025-12-31 | $683.19M | +184.4% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $150.83M | +114.5% |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $150.93M | +63.8% |
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | $633.16M | -20.7% |
| Adagene Inc. (ADAG) | 2025-12-31 | $78.26M | -12.3% |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | $56.75M | -43.0% |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $160.46M | -27.2% |
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | $49.95M | +12.6% |
Compare KRRO, IMNM, WHWK, OVID side by side · Screen every company in Pharmaceutical Preparations ↗